Browse studies

Find your next paid study

1 recruiting study matching your filters

Targeted Astatine-211-Labeled BC8-B10 Monoclonal Antibody as Reduced Intensity Conditioning for Nonmalignant Diseases

This phase I/II trial studies the best dose of total body irradiation with astatine-211 BC8-B10 monoclonal antibody for the treatment of patients with nonmalig…

Non-Malignant Neoplasm

Fred Hutchinson Cancer CenterNCT04083183